Jong, S;
Marston, L;
(2012)
After the life sciences strategy: managing science-based R&D collaborations.
UCL/NESTA: London, UK.
![[thumbnail of NESTALifeScieventnotes.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) |
PDF
NESTALifeScieventnotes.pdf Available under License : See the attached licence file. Download (354kB) |
Abstract
This event looked at the challenges of managing academic collaborations in commercial R&D projects in UK life sciences. Speaking at this event were CSOs of some of the UK's leading therapeutic biotechnology firms including Astex Pharmaceuticals, ReNeuron, Summit, and Vernalis. Further perspectives were presented by David T Phillips, Partner at SR One (the corporate venture capital arm of GlaxoSmithKline) and Dave Tapolczay, CEO of MRC Technology. The event was hosted by Louise Marston of NESTA and Simcha Jong, Lecturer in Management Science and Innovation from UCL who discussed his UK Innovation Research Initiative project on the international competitive position of UK R&D-intensive life sciences firms. It was followed by short presentations from the speakers about their experiences with organising science-intensive R&D projects. Support for this event is acknowledged from the Innovation Research Initiative program that is jointly funded by BIS, the TSB, the ESRC, and NESTA.
| Type: | Report |
|---|---|
| Title: | After the life sciences strategy: managing science-based R&D collaborations |
| Open access status: | An open access version is available from UCL Discovery |
| Language: | English |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > UCL School of Management |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1443529 |
Archive Staff Only
 |
View Item |
